search
Back to results

Implementation of Foot Thermometry and SMS and Voice Messaging to Prevent Diabetic Foot Ulcer

Primary Purpose

Diabetic Foot

Status
Completed
Phase
Not Applicable
Locations
Peru
Study Type
Interventional
Intervention
SMS and voice messaging
Thermometry
Sponsored by
Universidad Peruana Cayetano Heredia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Diabetic Foot focused on measuring Diabetic Neuropathies, Thermometry, Diabetes Mellitus, Type 2, Foot Ulcer, Telemedicine

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of type 2 diabetes mellitus.
  • Dorsalis pedis pulse in both feet.
  • In risk group 2 or 3 using the diabetic foot risk classification system as specified by the International Working Group on the Diabetic Foot.
  • Operating cell phone or a caregiver with an operating cell phone.
  • Ability to provide informed consent.

Exclusion Criteria:

  • Current ulcers or open amputation sites.
  • Active osteoarthropathy
  • Severe peripheral vascular disease
  • Foot infection

Sites / Locations

  • Hospital Cayetano Heredia
  • Hospital Nacional Arzobispo Loayza

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Thermometry-only group

Thermometry plus SMS and voice messaging

Arm Description

Subjects will be provided with a TempStat (foot thermometer), a device that captures a thermal image of feet. Some alarm signs have been pre-specified: 1) thermal image shows yellow spots in any area of feet for two consecutive days, 2) thermal image shows different colors in contralateral areas of the feet for two consecutive days or, 3) a dermal lesion. In any of these three scenarios, subjects will be instructed to contact the study nurse by phone. (See Detailed Description for more detail on the actions after an alarm sign has been observed)

Thermometry-related intervention activities will be the same as those established for the thermometry-only group. In addition, this group will receive reminders to use the TempStat (two messages) and promote foot care (six messages). The content of these eight messages has been developed and validated through both SMS and voice messaging. During the first two weeks of the intervention, only reminders to use the TempStat will be sent, daily, Monday to Friday, both via SMS and voice messaging. Hereafter, for the remaining 76 weeks, patients will only receive two messages per week, one SMS and one voice message, alternating content (reminders to use TempStat and promotion of foot care).

Outcomes

Primary Outcome Measures

Foot ulceration
The primary outcome is foot ulceration occurring at any point during the 12 month study duration. Foot ulceration will be defined using the American Diabetes Association criteria, which defines ulcers as any break in the cutaneous barrier; that usually extend through the full thickness of the dermis. There will be two ways of identifying if a patient has developed foot ulceration: (1) during the clinical evaluations done by a nurse every 2 months. (2) In addition to these bimonthly assessments, patients will be advised to make telephone calls to the study's nurse to report the presence of an ulcer, and he/she will be asked to go to the hospital for a face-to-face evaluation to be conducted by a masked nurse.

Secondary Outcome Measures

Adherence to daily temperature measurement
Adherence to temperature measurements will be based on patient self-report of foot temperature monitoring through recording in patient's logbooks.
Report of an alarm sign to the nurse
Compare the frequency of alarms signs reported to the study nurse
Report of an alarm sign in the logbook
Compare the frequency of alarms signs reported in the patient's logbooks.
Dose-response analysis of SMS and voice messaging
Dose-response per protocol analysis will be performed.
Glycosilated hemoglobin control targets
Reduce of 1% or more of glycosylated hemoglobin.

Full Information

First Posted
February 20, 2015
Last Updated
December 13, 2017
Sponsor
Universidad Peruana Cayetano Heredia
Collaborators
Johns Hopkins University, Mayo Clinic, University of Southern California
search

1. Study Identification

Unique Protocol Identification Number
NCT02373592
Brief Title
Implementation of Foot Thermometry and SMS and Voice Messaging to Prevent Diabetic Foot Ulcer
Official Title
Implementation of Foot Thermometry and SMS and Voice Messaging to Prevent Diabetic Foot Ulcer
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
September 2015 (Actual)
Primary Completion Date
September 2017 (Actual)
Study Completion Date
October 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad Peruana Cayetano Heredia
Collaborators
Johns Hopkins University, Mayo Clinic, University of Southern California

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to implement daily temperature measurements of feet complemented by SMS and voice messaging to prevent diabetic foot ulcers in patients with type 2 diabetes mellitus at high risk of ulceration. Design: Physician-blinded, randomized, 18-month trial. Setting: Diabetes outpatient clinics from two public hospitals Population: Subjects will be eligible if they (1) have a diagnosis of type 2 diabetes mellitus, (2) are between 18 - 80 years of age, (3) have a present dorsalis pedis pulse in both feet, (4) are in risk group 2 or 3 using the diabetic foot risk classification system as specified by the International Working Group on the Diabetic Foot, (5) have an operating cell phone or a caregiver with an operating cell phone, and (6) have the ability to provide informed consent. Hypothesis: The investigators hypothesize that implementation of an enhanced intervention that combines daily temperature measurement for the reduction of diabetic foot ulcer with SMS and voice messaging will improve patient measurement compliance and reduce diabetic foot ulcers in a middle income country.
Detailed Description
Detailed Description: Thermometry is a promising emerging modality for the prevention of diabetic foot ulcers according to different clinical trials. However, patient compliance with self-monitoring temperature at home is a concern, as they may be forgetful or find it difficult to get into a consistent routine of daily monitoring. Therefore, the investigators propose to determine the utility of SMS and voice messaging to remind the patients to perform the thermometry, and to assess the impact on diabetic foot ulceration. Specific Aims are: Compare the incidence of diabetic foot ulceration during the study between the arm that receives thermometry alone and the arm that receives thermometry plus SMS and voice messaging. Compare the compliance with foot thermometer use between the two study arms. Compare the frequency of alarms signs reported to the study nurse in the two study arms. Compare the frequency of alarms signs reported in the patient's logbooks in the two study arms. Compare the incidence of diabetic foot ulceration according to pre-specified sub-groups: caregiving status, and use of insoles and/or orthopedic shoes. In the intervention-only group, compare the incidence of diabetic foot ulcers by varying the recipient of the messaging intervention (patient vs caregivers). Intervention: Placebo Comparator: Thermometry-only group. Subjects will be provided with a TempStat (foot thermometer), a device that captures a thermal image of feet through colors. Some alarm signs have been pre-specified: 1) When the thermal image shows yellow spots in any area of any feet for two consecutive days, 2) when the thermal image shows different colors in contralateral areas of the feet for two consecutive days or, 3) a dermal lesion is detected at any time. In any of these three scenarios, subjects will be instructed to contact the study nurse by phone or text message. For the first two types of alarm signs, once the study nurse is contacted he/ she will ask about the presence of lesions in the patient's feet and the patient's activity on the previous two weeks, and will provide recommendations on how to decrease activity until temperatures normalize. If TempStat measurements continue to show alarm signs for more than one week after the telephone consultation, the participant will be asked to contact the nurse and schedule a face-to-face evaluation to assess the presence of an infection and/or ulcer with a masked assessor. In the third type of alarm sign, presence of a dermal lesion, participants will be asked to contact the study's nurse and he/she will make an appointment for an evaluation with a nurse blind to the intervention. When the main outcome, foot ulceration, has been confirmed, patients will be directed by the study nurse to receive professional care by a specialist. Experimental: Thermometry plus SMS and voice messaging Thermometry-related intervention activities will be the same as those established for the thermometry-only group. In addition, this group will receive reminders to use the TempStat (two messages) and promote foot care (six messages). The content of these eight messages has been developed and validated through both via SMS and voice messaging. During the first two weeks of the intervention, only reminders to use the TempStat will be sent, daily, Monday to Friday, both SMS and voice messaging. Hereafter, for the remaining 76 weeks, patients will only receive two messages per week, one SMS and one voice message, alternating content (reminders to use TempStat and promotion of foot care).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Foot
Keywords
Diabetic Neuropathies, Thermometry, Diabetes Mellitus, Type 2, Foot Ulcer, Telemedicine

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
172 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Thermometry-only group
Arm Type
Placebo Comparator
Arm Description
Subjects will be provided with a TempStat (foot thermometer), a device that captures a thermal image of feet. Some alarm signs have been pre-specified: 1) thermal image shows yellow spots in any area of feet for two consecutive days, 2) thermal image shows different colors in contralateral areas of the feet for two consecutive days or, 3) a dermal lesion. In any of these three scenarios, subjects will be instructed to contact the study nurse by phone. (See Detailed Description for more detail on the actions after an alarm sign has been observed)
Arm Title
Thermometry plus SMS and voice messaging
Arm Type
Experimental
Arm Description
Thermometry-related intervention activities will be the same as those established for the thermometry-only group. In addition, this group will receive reminders to use the TempStat (two messages) and promote foot care (six messages). The content of these eight messages has been developed and validated through both SMS and voice messaging. During the first two weeks of the intervention, only reminders to use the TempStat will be sent, daily, Monday to Friday, both via SMS and voice messaging. Hereafter, for the remaining 76 weeks, patients will only receive two messages per week, one SMS and one voice message, alternating content (reminders to use TempStat and promotion of foot care).
Intervention Type
Behavioral
Intervention Name(s)
SMS and voice messaging
Intervention Description
This group will receive reminders to use the TempStat (two messages) and promote foot care (six messages). The content of these eight messages have been developed and validated their delivery through both, SMS and voice messaging. During the first two weeks of the intervention, only reminders to use the TempStat will be sent, daily, Monday to Friday, both via SMS and voice messaging. Hereafter, for the remaining 76 weeks, patients will only receive two messages per week, one SMS and one voice message, alternating content (reminders to use TempStat and promotion of foot care).
Intervention Type
Device
Intervention Name(s)
Thermometry
Intervention Description
Subjects will be provided with a TempStat (foot thermometer), a device that captures a thermal image of feet. (See Detailed description)
Primary Outcome Measure Information:
Title
Foot ulceration
Description
The primary outcome is foot ulceration occurring at any point during the 12 month study duration. Foot ulceration will be defined using the American Diabetes Association criteria, which defines ulcers as any break in the cutaneous barrier; that usually extend through the full thickness of the dermis. There will be two ways of identifying if a patient has developed foot ulceration: (1) during the clinical evaluations done by a nurse every 2 months. (2) In addition to these bimonthly assessments, patients will be advised to make telephone calls to the study's nurse to report the presence of an ulcer, and he/she will be asked to go to the hospital for a face-to-face evaluation to be conducted by a masked nurse.
Time Frame
18 months
Secondary Outcome Measure Information:
Title
Adherence to daily temperature measurement
Description
Adherence to temperature measurements will be based on patient self-report of foot temperature monitoring through recording in patient's logbooks.
Time Frame
18 months
Title
Report of an alarm sign to the nurse
Description
Compare the frequency of alarms signs reported to the study nurse
Time Frame
18 months
Title
Report of an alarm sign in the logbook
Description
Compare the frequency of alarms signs reported in the patient's logbooks.
Time Frame
18 months
Title
Dose-response analysis of SMS and voice messaging
Description
Dose-response per protocol analysis will be performed.
Time Frame
18 months
Title
Glycosilated hemoglobin control targets
Description
Reduce of 1% or more of glycosylated hemoglobin.
Time Frame
18 months
Other Pre-specified Outcome Measures:
Title
Sub-group analyses, all participants
Description
The primary outcome will be subjected to pre-specified heterogeneity in treatment effects. In the following analyses, variables will be considered positive if its presence/usage is reported at baseline and in at the last evaluation of the participant during study period. Caregiving status, assistance provided to the patient with i) basic activities of daily living, or ii) in the identification, prevention, or treatment of diabetes or any disability. Use of insoles and/or orthopedic shoes.
Time Frame
18 months
Title
Sub-group analyses, intervention group only
Description
1)In order to receive the SMS and voice messaging, the intervention requires ownership of a cell phone by either the patient or its caregiver. This sub-group analysis will explore the primary outcome by the type of recipient (patient vs caregivers) of the messaging intervention.
Time Frame
18 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of type 2 diabetes mellitus. Dorsalis pedis pulse in both feet. In risk group 2 or 3 using the diabetic foot risk classification system as specified by the International Working Group on the Diabetic Foot. Operating cell phone or a caregiver with an operating cell phone. Ability to provide informed consent. Exclusion Criteria: Current ulcers or open amputation sites. Active osteoarthropathy Severe peripheral vascular disease Foot infection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jaime Miranda, MD, PhD
Organizational Affiliation
Universidad Peruana Cayetano Heredia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Cayetano Heredia
City
Lima
ZIP/Postal Code
Lima 31
Country
Peru
Facility Name
Hospital Nacional Arzobispo Loayza
City
Lima
ZIP/Postal Code
Lima 5
Country
Peru

12. IPD Sharing Statement

Citations:
PubMed Identifier
27094007
Citation
Lazo-Porras M, Bernabe-Ortiz A, Sacksteder KA, Gilman RH, Malaga G, Armstrong DG, Miranda JJ. Implementation of foot thermometry plus mHealth to prevent diabetic foot ulcers: study protocol for a randomized controlled trial. Trials. 2016 Apr 19;17(1):206. doi: 10.1186/s13063-016-1333-1.
Results Reference
background
PubMed Identifier
32923686
Citation
Lazo-Porras M, Bernabe-Ortiz A, Taype-Rondan A, Gilman RH, Malaga G, Manrique H, Neyra L, Calderon J, Pinto M, Armstrong DG, Montori VM, Miranda JJ. Foot thermometry with mHeath-based supplementation to prevent diabetic foot ulcers: A randomized controlled trial. Wellcome Open Res. 2020 Aug 28;5:23. doi: 10.12688/wellcomeopenres.15531.2. eCollection 2020.
Results Reference
derived

Learn more about this trial

Implementation of Foot Thermometry and SMS and Voice Messaging to Prevent Diabetic Foot Ulcer

We'll reach out to this number within 24 hrs